№ files_lp_3_process_9_65067
File format: docx
Character count: 3961
File size: 35 KB
Referral form for diagnostic assessments for adults with autism spectrum conditions or ADHD, to be completed by clinicians for individuals aged 18 or over.
Note:
Date
Region / city:
Devon (excluding Plymouth)
Topic:
Autism Spectrum Conditions, ADHD
Document type:
Referral Form
Author:
Devon Adult Autism and ADHD Service
Target audience:
General Practitioners, Clinicians
Period of validity:
N/A
Date of approval:
N/A
Date of changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Region / City:
Jacksonville, Florida
Subject:
Disability Documentation
Document Type:
Verification Form
Institution:
University of North Florida
Author:
Student Accessibility Center
Target Audience:
Students with Attention Deficit Hyperactivity Disorder (ADHD)
Period of Validity:
Current Documentation Required
Year:
2017
Region / city:
Greater Manchester, UK
Theme:
ADHD, Medication, Shared Care Protocol
Document Type:
Medical Guideline
Organization:
Pennine Care NHS Foundation Trust, CMFT
Author:
Dr. Prathiba Chitsabesan, Arifa Raza Azmi, Dr. Hilary Lloyd
Target Audience:
Healthcare professionals
Approval Date:
13.7.2017 (Pathways and Guidelines Development Subgroup), 17.8.2017 (Greater Manchester Medicines Management Group)
Review Date:
17.8.2020
Date of Issue:
17.8.2017
Date of Replacement:
17.8.2017
Reference Number:
ATOMOXETINE FOR THE TREATMENT OF ATTENTION HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS
Version:
2.2
Replaces:
2.1
Issue date:
17.8.2017
Review date:
17.8.2020
Authors:
Dr Prathiba Chitsabesan – Healthy Young Minds Consultant, Pennine Care NHS Foundation Trust; Arifa Raza Azmi – Clinical Pharmacist, Pennine Care NHS Foundation Trust
Approving body:
Pathways and Guidelines Development Subgroup
Date approved by Pathways and Guidelines Development Subgroup:
13.7.2017
Note:
Approving body
Greater Manchester Medicines Management Group
Date approved by Greater Manchester Medicines Management Group:
17.8.2017
Organisation:
Pennine Care NHS Foundation Trust
Region:
Greater Manchester
Therapeutic area:
Attention Deficit Hyperactivity Disorder (ADHD)
Medicine:
Atomoxetine hydrochloride
Dosage forms:
Hard capsules (10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg); 4mg/ml oral solution
Licensed population:
Children and adolescents aged 6 years and above
Document type:
Shared Care Guideline / Shared Care Protocol
Related documents:
Summary of Product Characteristics; BNF
Indication:
Severe or moderate ADHD impairment where psychological/behavioural measures alone are insufficient
Contraindications:
Hypersensitivity to atomoxetine; concomitant use with MAOIs; severe cardiovascular or cerebrovascular disorders without specialist advice; narrow angle glaucoma; pheochromocytoma; hereditary fructose intolerance (oral solution)
Pregnancy and lactation status:
Prescribing responsibility remains with the Specialist
Year:
2021
Region / City:
Australia
Topic:
Drug Utilisation for ADHD
Document Type:
Utilisation Analysis
Organization / Institution:
Drug Utilisation Sub-Committee (DUSC)
Author:
Not specified
Target Audience:
Healthcare professionals, policymakers
Period of Validity:
2014-2020
Approval Date:
June 2021
Date of Changes:
Not specified
Note:
Year
Region / City:
Jacksonville, Florida
Subject:
Disability Documentation
Document Type:
Verification Form
Institution:
University of North Florida
Author:
Student Accessibility Center
Target Audience:
Students with Attention Deficit Hyperactivity Disorder (ADHD)
Period of Validity:
Current Documentation Required
Year:
2017
Region / city:
Greater Manchester, UK
Theme:
ADHD, Medication, Shared Care Protocol
Document Type:
Medical Guideline
Organization:
Pennine Care NHS Foundation Trust, CMFT
Author:
Dr. Prathiba Chitsabesan, Arifa Raza Azmi, Dr. Hilary Lloyd
Target Audience:
Healthcare professionals
Approval Date:
13.7.2017 (Pathways and Guidelines Development Subgroup), 17.8.2017 (Greater Manchester Medicines Management Group)
Review Date:
17.8.2020
Date of Issue:
17.8.2017
Date of Replacement:
17.8.2017
Year:
2019
Region / City:
Oeiras, Portugal; Ghent, Belgium
Topic:
Plant Science, Crop Yield, Drought Tolerance
Document Type:
Article
Author:
Joana Rodrigues, Dirk Inzé, Hilde Nelissen, Nelson J.M. Saibo
Target Audience:
Researchers, Agronomists, Biotechnologists
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Year
Topic:
Ethics, Compliance
Document Type:
Code of Professional Ethics
Organization / Institution:
CMHCM
Target Audience:
Providers, Mental Health Professionals
Year:
2021
Region / City:
Australia
Topic:
Drug Utilisation for ADHD
Document Type:
Utilisation Analysis
Organization / Institution:
Drug Utilisation Sub-Committee (DUSC)
Author:
Not specified
Target Audience:
Healthcare professionals, policymakers
Period of Validity:
2014-2020
Approval Date:
June 2021
Date of Changes:
Not specified
Year:
2023–2025
Location:
ICAR- National Institute of Abiotic Stress Management, Malegaon, Baramati, Maharashtra, India
Crop:
Mango (Mangifera indica L.) cv. Kesar
Subject:
Plant growth regulators, biostimulant and deficit irrigation
Irrigation Regimes:
100% ETc and 75% ETc
Experimental Design:
Split plot design with three replications
Treatment Combinations:
Fourteen (T1–T14)
Plant Growth Regulators:
Salicylic acid (200 ppm), CPPU (2.5 ppm)
Biostimulant:
Seaweed extract (4 ml/litre)
Phenological Stages of Application:
Flowering (December–January), Fruit development (February–March), Maturity (April–May)
Parameters Studied:
Vegetative growth, canopy characteristics, yield attributes, biochemical traits
Key Measurements:
Plant height, canopy spread, canopy volume, fruit number, fruit yield, TSS, ascorbic acid, titrable acidity
Document Type:
Experimental research study
Note:
Year
Topic:
Attention Deficit Disorder, Biochemical Causes, ADHD
Document Type:
Article
Year:
2026
Region / City:
United States
Topic:
Nursing, Fluid and Electrolyte Management
Document Type:
Educational/Clinical Guidelines
Institution / Organization:
Nursing Education Resource
Author:
Not specified
Target Audience:
Nursing students, clinical nurses
Effective Period:
Ongoing clinical reference
Date of Approval:
Not specified
Date of Revision:
Not specified
Clinical Focus:
Hypovolemia, Shock, IV Fluid Administration
Patient Conditions:
Dehydration, Burns, Ascites, Diabetes, Polyuria
Safety Considerations:
Orthostatic hypotension, Fall risk, Fluid overload monitoring
IV Fluids Covered:
Isotonic, Hypotonic, Hypertonic solutions
Year:
2012
Month:
December
Country:
United States
City / Local Government:
City of __________________
Document Type:
Sample Letter
Topic:
Tax policy; municipal bonds; public infrastructure financing
Recipient Institution:
U.S. House of Representatives
Recipient:
The Honorable __________________
Issuing Party:
City of __________________
Referenced Organization:
League of California Cities
Policy Issue:
Federal deficit reduction plan and proposed cap on tax-exempt municipal bond interest
Economic Sector:
Public finance and infrastructure investment
Historical Reference:
Federal tax exemption for municipal bonds since 1913
Intended Audience:
Member of the U.S. Congress
Geographical Scope:
United States; state and local governments
Associated Infrastructure:
Roads, bridges, sewers, dams, schools, hospitals, airports, water systems, and public transportation